Neuroblastoma: drug-induced differentiation increases proportion of cytoplasmic RNA that contains polyadenylic acid

Science. 1974 Oct 25;186(4161):359-61. doi: 10.1126/science.186.4161.359.

Abstract

The production of cytoplasmic RNA that contains polyadenylic acid is increased, relative to total cytoplasmic RNA, in a neuroblastoma clone, NBE-(A), after induction of differentiation by 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone, an inhibitor of adenosine 3',5'-monophosphate phosphodiesterase. The amount of RNA that contains polyadenylic acid in cytoplasm may be greater in such differentiated neuroblastoma cells than in proliferating control cells.

MeSH terms

  • Acetyltransferases / metabolism
  • Adenosine / metabolism
  • Adenosine Monophosphate / biosynthesis
  • Adenosine Monophosphate / metabolism*
  • Animals
  • Benzyl Compounds / pharmacology
  • Brain / cytology
  • Cell Differentiation / drug effects
  • Chickens
  • Choline
  • Clone Cells / metabolism
  • Culture Media
  • Cyclic AMP
  • Cytoplasm / metabolism
  • Ethers / pharmacology
  • Imidazoles / pharmacology
  • Microscopy, Phase-Contrast
  • Neuroblastoma / metabolism*
  • Neuroblastoma / pathology
  • Phosphodiesterase Inhibitors
  • Polynucleotides / metabolism*
  • RNA, Neoplasm / biosynthesis
  • RNA, Neoplasm / metabolism*
  • RNA, Ribosomal / metabolism
  • Tritium

Substances

  • Benzyl Compounds
  • Culture Media
  • Ethers
  • Imidazoles
  • Phosphodiesterase Inhibitors
  • Polynucleotides
  • RNA, Neoplasm
  • RNA, Ribosomal
  • Tritium
  • Adenosine Monophosphate
  • Cyclic AMP
  • Acetyltransferases
  • Adenosine
  • Choline